TABLE 1.
Study data and testing methods (1997 to 2000) in a study examining antimicrobial resistance among Salmonella and Shigella isolates in five Canadian provinces
| Province | Antimicrobial resistance testing method | Salmonella | Shigella | ||
|---|---|---|---|---|---|
| Isolates tested, n (%) | Median number of antimicrobials tested (range) | Isolates tested, n (%) | Median number of antimicrobialstested (range) | ||
| Alberta | VITEK (GNS 606 cards)* | 1559 (25) | 13 (1–19) | 583 (35) | 12 (4–20) |
| Newfoundland and Labrador | Disk diffusion | 26 (0.42) | 9 (8–9) | 0 (0.0) | –† |
| Ontario | Agar dilution | 3959 (64) | 14 (1–17) | 884 (53) | 14 (4–17) |
| Prince Edward Island | Microscan (Panel 12)‡ | 87 (1.4) | 32 (29–32) | 3 (0.18) | 32 (32) |
| Saskatchewan | Microscan (Panel 5)‡ | 588 (9.5) | 12 (6–22) | 203 (12) | 12 (1–24) |
| Total | – | 6219 (100) | 14 (1–32) | 1673 (100) | 14 (1–32) |
*
bioMérieux Vitek, USA;
†
No test results for Shigella isolates were provided for Newfoundland and Labrador;
‡
Dade International, USA